Blue Owl Capital (BMEA) discloses 5.92% Biomea Fusion stake via warrants

Rhea-AI Filing Summary

Blue Owl Capital Holdings LP filed a Schedule 13G reporting beneficial ownership in Biomea Fusion, Inc. common stock. The firm reports beneficial ownership of 4,451,219 shares of common stock issuable upon exercise of warrants, representing 5.92% of the class.

Blue Owl has shared voting and shared dispositive power over these 4,451,219 warrant shares and no sole voting or dispositive power. The ownership percentage is calculated using 70,703,639 shares of common stock outstanding as of October 31, 2025, increased by the warrant shares. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Biomea Fusion.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Biomea Fusion, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

09077A106

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 09077A106

1

Names of Reporting Persons

Blue Owl Capital Holdings LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,451,219.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,451,219.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,451,219.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.92 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: The reported securities represent 4,451,219 shares of Common Stock issuable upon exercise of warrants to each acquire one share of Common Stock ("Warrants"). The percentage of class is calculated based upon 70,703,639 shares of Common Stock outstanding as of October 31, 2025, as reported on the Issuer's 10-Q filed with the Securities and Exchange Commission on November 4, 2025, as increased by the 4,451,219 shares of Common Stock issuable upon exercise of the Warrants.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Biomea Fusion, Inc.
(b)	Address of issuer's principal executive offices: 1599 INDUSTRIAL ROAD SAN CARLOS, CA, 94070
Item 2.
(a)	Name of person filing: This statement is filed by the Blue Owl Capital Holdings LP, referred to herein as the "Reporting Person."
(b)	Address or principal business office or, if none, residence: 399 Park Avenue New York, New York 10022
(c)	Citizenship: See response to Item 4 on the cover page.
(d)	Title of class of securities: Common Stock, $0.0001 par value per share
(e)	CUSIP No.: 09077A106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on the cover page. The filing of this statement shall not be deemed an admission by any of the Reporting Persons, of beneficial ownership of the reported securities for purposes of Section 13(d) or Section 13(g) or for any other purpose.
(b)	Percent of class: See response to Item 11 on the cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on the cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on the cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on the cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on the cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Blue Owl Capital Holdings LP

Signature:	/s/ Karen Hager
Name/Title:	Karen Hager/Chief Compliance Officer
Date:	02/12/2026

FAQ

What stake does Blue Owl Capital Holdings report in Biomea Fusion (BMEA)?

Blue Owl Capital Holdings reports beneficial ownership of 4,451,219 shares of Biomea Fusion common stock issuable upon exercise of warrants, representing 5.92% of the class. The percentage is based on 70,703,639 shares outstanding as of October 31, 2025, plus these warrant shares.

How did Blue Owl Capital Holdings’ 5.92% ownership in BMEA get calculated?

The 5.92% figure is based on 70,703,639 Biomea Fusion common shares outstanding as of October 31, 2025, as disclosed in a 10-Q, increased by 4,451,219 shares issuable upon exercise of Blue Owl’s warrants. That combined total forms the denominator used to compute the ownership percentage.

What type of Biomea Fusion securities does Blue Owl Capital Holdings hold?

Blue Owl holds warrants exercisable for 4,451,219 shares of Biomea Fusion common stock. Each warrant entitles the holder to acquire one share of common stock. These warrant shares are treated as beneficially owned for reporting, even though they are not yet outstanding common shares.

Does Blue Owl Capital Holdings seek to influence control of Biomea Fusion (BMEA)?

The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Biomea Fusion. It also specifies they are not held in connection with any transaction having that control-related purpose or effect.

What voting and dispositive powers does Blue Owl have over its BMEA position?

Blue Owl reports shared voting power and shared dispositive power over 4,451,219 shares issuable upon exercise of warrants, and no sole voting or sole dispositive power. This means decisions to vote or sell the underlying shares are shared with at least one other party, as reflected in the Schedule 13G.

When did Blue Owl’s reportable ownership event in Biomea Fusion occur?

The Schedule 13G identifies December 31, 2025 as the date of the event requiring the filing. This is the reference date on which Blue Owl’s beneficial ownership position became reportable under applicable beneficial ownership reporting rules for Biomea Fusion common stock.